Document Detail


Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis.
MedLine Citation:
PMID:  14767289     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Interstitial cystitis (IC) is one of the most bothersome conditions in urological practice. There are 2 subtypes, classic and nonulcer IC, with similar symptoms but different outcomes with respect to clinical course and response to treatment. Histologically there are fundamental differences between the 2 subtypes, classic IC presenting a severe abnormality of the urothelium and characteristic inflammatory cell infiltrates while inflammation is scant in nonulcer IC. Regulation of urinary nitric oxide synthase activity has been proposed to be of importance for immunological responses in IC. We present evidence of a profound difference between the 2 subtypes concerning nitric oxide production, mirroring the differences in inflammatory response in IC. MATERIALS AND METHODS: A total of 17 patients with both subtypes and active disease as well as patients with disease in remission were included in the study, all diagnosed according to National Institute for Diabetes and Digestive and Kidney Diseases criteria. Luminal nitric oxide was measured in the bladder of patients using a chemiluminescence nitric oxide analyzer. RESULTS: All patients with classic IC had high levels of NO. None of the other patients had any significant increase in NO levels in the bladder. The NO level in patients with classic IC was not related to symptoms but rather to the assignment to this specific subgroup of IC. The highest levels of NO were found in patients in the initial phase of classic IC. CONCLUSIONS: The difference in NO evaporation between classic and nonulcer IC allows for subtyping of cases meeting National Institute for Diabetes and Digestive and Kidney Diseases criteria without performing cystoscopy. The findings in the present series together with previous findings clearly demonstrate that the 2 subtypes of IC represent separate entities. This separation further emphasizes the need to subtype all cases included in all scientific matters, ensuring that the 2 subtypes are evaluated separately in clinical studies.
Authors:
Y R Logadottir; Ingrid Ehren; Magnus Fall; N Peter Wiklund; Ralph Peeker; Philip M Hanno
Related Documents :
17939309 - Evaluation of male anterior urethral strictures by ultrasonography compared with retrog...
15332759 - Gall bladder sludge and stones in multitransfused egyptian thalassaemic patients.
1097579 - Hematospermia.
9810939 - Urodynamic evaluation of patients with autosomal dominant pure spastic paraplegia linke...
7833969 - Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation c...
11641859 - Urinary incontinence. screening and treatment of urinary dysfunction.
15251659 - Variations in adequate levothyroxine replacement therapy in patients with different cau...
10618619 - Tumor markers at the time of recurrence in patients with germ cell tumors.
1862019 - Childhood leprosy in northern india.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of urology     Volume:  171     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-02-09     Completed Date:  2004-03-30     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1148-50; discussion 50-1     Citation Subset:  AIM; IM    
Affiliation:
Department of Urology, Sahlgrenska University Hospital, Götenborg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cystitis, Interstitial / diagnosis*,  metabolism*
Diagnosis, Differential
Female
Humans
Male
Middle Aged
Nitric Oxide / biosynthesis*
Urinary Bladder / metabolism*
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide
Comments/Corrections
Comment In:
J Urol. 2004 Nov;172(5 Pt 1):2083; author reply 2083   [PMID:  15540795 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical fa...
Next Document:  Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen inj...